BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 7706498)

  • 1. MCF-7 breast cancer cells transfected with protein kinase C-alpha exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotype.
    Ways DK; Kukoly CA; deVente J; Hooker JL; Bryant WO; Posekany KJ; Fletcher DJ; Cook PP; Parker PJ
    J Clin Invest; 1995 Apr; 95(4):1906-15. PubMed ID: 7706498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of a less aggressive breast cancer phenotype by protein kinase C-alpha and -beta overexpression.
    Manni A; Buckwalter E; Etindi R; Kunselman S; Rossini A; Mauger D; Dabbs D; Demers L
    Cell Growth Differ; 1996 Sep; 7(9):1187-98. PubMed ID: 8877100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stable transfection of protein kinase C alpha cDNA in hormone-dependent breast cancer cell lines.
    Tonetti DA; Chisamore MJ; Grdina W; Schurz H; Jordan VC
    Br J Cancer; 2000 Sep; 83(6):782-91. PubMed ID: 10952784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of protein kinase C-alpha in MCF-7 breast cancer cells results in differential regulation and expression of alphavbeta3 and alphavbeta5.
    Carey I; Williams CL; Ways DK; Noti JD
    Int J Oncol; 1999 Jul; 15(1):127-36. PubMed ID: 10375605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced expression of Wnt-1 and E-cadherin, and diminished beta-catenin stability in MCF-7 breast cancer cells that overexpress protein kinase C-alpha.
    Williams CL; Noti JD
    Int J Oncol; 2001 Dec; 19(6):1227-33. PubMed ID: 11713593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of inhibition of PKC alpha on breast cancer cell phenotype and expressions of cyclin E and CDK2].
    Sang JL; Wang YC
    Shi Yan Sheng Wu Xue Bao; 1999 Dec; 32(4):367-71. PubMed ID: 12548864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to osteopontin via alphavbeta3 suppresses phorbol ester-mediated apoptosis in MCF-7 breast cancer cells that overexpress protein kinase C-alpha.
    Noti JD
    Int J Oncol; 2000 Dec; 17(6):1237-43. PubMed ID: 11078811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated levels of ERK2 in human breast carcinoma MCF-7 cells transfected with protein kinase C alpha.
    Gupta AK; Galoforo SS; Berns CM; Martinez AA; Corry PM; Guan KL; Lee YJ
    Cell Prolif; 1996 Dec; 29(12):655-63. PubMed ID: 9146728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of protein kinase C epsilon is oncogenic in rat colonic epithelial cells.
    Perletti GP; Folini M; Lin HC; Mischak H; Piccinini F; Tashjian AH
    Oncogene; 1996 Feb; 12(4):847-54. PubMed ID: 8632907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase C beta enhances growth and expression of cyclin D1 in human breast cancer cells.
    Li H; Weinstein IB
    Cancer Res; 2006 Dec; 66(23):11399-408. PubMed ID: 17145886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of PKC-delta contributes to antiestrogen resistance in mammary tumor cells.
    Nabha SM; Glaros S; Hong M; Lykkesfeldt AE; Schiff R; Osborne K; Reddy KB
    Oncogene; 2005 Apr; 24(19):3166-76. PubMed ID: 15735693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein kinase C and its isoforms in human breast cancer cells: relationship to the invasive phenotype.
    Morse-Gaudio M; Connolly JM; Rose DP
    Int J Oncol; 1998 Jun; 12(6):1349-54. PubMed ID: 9592198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased PKC-alpha expression increases cellular proliferation, decreases differentiation, and enhances the transformed phenotype of CaCo-2 cells.
    Scaglione-Sewell B; Abraham C; Bissonnette M; Skarosi SF; Hart J; Davidson NO; Wali RK; Davis BH; Sitrin M; Brasitus TA
    Cancer Res; 1998 Mar; 58(5):1074-81. PubMed ID: 9500474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of regulatory domains of specific isoforms of protein kinase C on growth control and apoptosis in MCF-7 breast cancer cells.
    Soh JW; Lee YS; Weinstein IB
    J Exp Ther Oncol; 2003; 3(3):115-26. PubMed ID: 14641818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phorbol esters induce death in MCF-7 breast cancer cells with altered expression of protein kinase C isoforms. Role for p53-independent induction of gadd-45 in initiating death.
    de Vente JE; Kukoly CA; Bryant WO; Posekany KJ; Chen J; Fletcher DJ; Parker PJ; Pettit GJ; Lozano G; Cook PP
    J Clin Invest; 1995 Oct; 96(4):1874-86. PubMed ID: 7560079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Definition by specific antisense oligonucleotides of a role for protein kinase C alpha in expression of differentiation markers in normal and neoplastic mouse epidermal keratinocytes.
    Lee YS; Dlugosz AA; McKay R; Dean NM; Yuspa SH
    Mol Carcinog; 1997 Jan; 18(1):44-53. PubMed ID: 9022812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional effects of overexpression of protein kinase C-alpha, -beta, -delta, -epsilon, and -eta in the mast cell line RBL-2H3.
    Chang EY; Szallasi Z; Acs P; Raizada V; Wolfe PC; Fewtrell C; Blumberg PM; Rivera J
    J Immunol; 1997 Sep; 159(6):2624-32. PubMed ID: 9300681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclooxygenase-2 uses the protein kinase C/ interleukin-8/urokinase-type plasminogen activator pathway to increase the invasiveness of breast cancer cells.
    Simeone AM; Nieves-Alicea R; McMurtry VC; Colella S; Krahe R; Tari AM
    Int J Oncol; 2007 Apr; 30(4):785-92. PubMed ID: 17332916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of protein kinase C delta by estrogen in the MCF-7 human breast cancer cell line.
    Shanmugam M; Krett NL; Maizels ET; Cutler RE; Peters CA; Smith LM; O'Brien ML; Park-Sarge OK; Rosen ST; Hunzicker-Dunn M
    Mol Cell Endocrinol; 1999 Feb; 148(1-2):109-18. PubMed ID: 10221776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of novel protein kinase C delta in BL6 murine melanoma cells inhibits the proliferative capacity in vitro but enhances the metastatic potential in vivo.
    La Porta CA; Di Dio A; Porro D; Comolli R
    Melanoma Res; 2000 Apr; 10(2):93-102. PubMed ID: 10803709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.